Ferrari-DiLeo G, Flynn D D
Department of Molecular & Cellular Pharmacology, University of Miami School of Medicine, Florida 33101.
Life Sci. 1993;53(25):PL439-44. doi: 10.1016/0024-3205(93)90037-4.
The functional integrity of the cortical muscarinic receptor (MR)-mediated phosphatidylinositol 4,5-bisphosphate (PIP2)-specific phospholipase C signalling pathway was assessed in Alzheimer disease (AD) and age-matched control subjects. There was no difference in the basal hydrolysis of [3H]-PIP2 to [3H]-inositol phosphates between control and AD membrane preparations. However, muscarinic agonist-stimulated PIP2 hydrolysis was significantly diminished in the AD cases. Diminished agonist-stimulated PIP2 hydrolysis correlated with the loss in high affinity agonist binding (KL/KH ratio) to the M1 muscarinic receptor subtype in the disease. These data further support the hypothesis that muscarinic receptor-mediated signal transduction is altered in AD, and that the defect lies at the level of muscarinic receptor-G protein/effector coupling.
在阿尔茨海默病(AD)患者和年龄匹配的对照受试者中,评估了皮质毒蕈碱受体(MR)介导的磷脂酰肌醇4,5-二磷酸(PIP2)特异性磷脂酶C信号通路的功能完整性。在对照和AD膜制剂之间,[3H]-PIP2向[3H]-肌醇磷酸的基础水解没有差异。然而,在AD病例中,毒蕈碱激动剂刺激的PIP2水解显著减少。激动剂刺激的PIP2水解减少与疾病中M1毒蕈碱受体亚型的高亲和力激动剂结合(KL/KH比值)丧失相关。这些数据进一步支持了以下假设:在AD中,毒蕈碱受体介导的信号转导发生改变,并且缺陷在于毒蕈碱受体-G蛋白/效应器偶联水平。